This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2off

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2off.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2off.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2off| PDB=2off | SCENE= }}
{{STRUCTURE_2off| PDB=2off | SCENE= }}
-
'''The crystal structure of Glycogen Phosphorylase b in complex with a potent allosteric inhibitor'''
+
===The crystal structure of Glycogen Phosphorylase b in complex with a potent allosteric inhibitor===
-
==Overview==
+
<!--
-
FR258900 has been discovered as a novel inhibitor of human liver glycogen phosphorylase a and proved to suppress hepatic glycogen breakdown and reduce plasma glucose concentrations in diabetic mice models. To elucidate the mechanism of inhibition, we have determined the crystal structure of the cocrystallized rabbit muscle glycogen phosphorylase b-FR258900 complex and refined it to 2.2 A resolution. The structure demonstrates that the inhibitor binds at the allosteric activator site, where the physiological activator AMP binds. The contacts from FR258900 to glycogen phosphorylase are dominated by nonpolar van der Waals interactions with Gln71, Gln72, Phe196, and Val45' (from the symmetry-related subunit), and also by ionic interactions from the carboxylate groups to the three arginine residues (Arg242, Arg309, and Arg310) that form the allosteric phosphate-recognition subsite. The binding of FR258900 to the protein promotes conformational changes that stabilize an inactive T-state quaternary conformation of the enzyme. The ligand-binding mode is different from those of the potent phenoxy-phthalate and acyl urea inhibitors, previously described, illustrating the broad specificity of the allosteric site.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17600143}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17600143 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17600143}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Type 2 diabetes]]
[[Category: Type 2 diabetes]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 10:47:46 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 15:32:41 2008''

Revision as of 12:32, 29 July 2008

Image:2off.png

Template:STRUCTURE 2off

The crystal structure of Glycogen Phosphorylase b in complex with a potent allosteric inhibitor

Template:ABSTRACT PUBMED 17600143

About this Structure

2OFF is a Single protein structure of sequence from Oryctolagus cuniculus. Full crystallographic information is available from OCA.

Reference

FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase., Tiraidis C, Alexacou KM, Zographos SE, Leonidas DD, Gimisis T, Oikonomakos NG, Protein Sci. 2007 Aug;16(8):1773-82. Epub 2007 Jun 28. PMID:17600143

Page seeded by OCA on Tue Jul 29 15:32:41 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2off"
Personal tools